Chemically known as tirzepatide, Mounjaro is currently sold in the UK and Europe under the same brand name for both diabetes ...
By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...
Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...
India Today on MSN3d
Mounjaro enters India as weight-loss drug, but doctors warn against misuseWhile experts welcomed Mounjaro's launch, they stressed the importance of responsible prescribing to prevent misuse of the drug used for the treatment of type 2 diabetes and obesity.
US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...
While asking about unpaid overtime might seem like a harmless question to some employers, it’s actually a major red flag that ...
In recent years, Chinese micro-dramas have taken social media platforms by storm, captivating millions of viewers with their ...
Misuse of the drug is a big concern According to Dr. Ambrish Mithal, Chairman & Head - Endocrinology & Diabetes, Max Healthcare, "obesity rates in India are rising at an alarming pace, fueling an ...
The Department of Environmental Science at Nagaland University organized a one-day symposium on “Innovation and Entrepreneurship in Environmental Science for a Sustainable Future” on March 18. The ...
In 2022, over 65% of all drug prescriptions in the US were for Ozempic alone. Dr Ambrish Mithal, chairman and head of endocrinology and diabetes at Max Healthcare, Delhi, told FE: “The launch is ...
Ingram Micro (NYSE: INGM), a business-to-business (B2B) platform company for the global technology ecosystem, is simplifying the technology industry's capabilities to innovate and more securely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback